UB
Highly rated in
20
conditions
Highly rated in
20
conditions
Check Dr. Usman M. Baber's experience treating your condition:
About Dr. Usman M. Baber

Usman Baber is an Interventional Cardiologist and a Cardiologist in Oklahoma City, Oklahoma. Baber has been practicing medicine for over 19 years and is highly rated in 20 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Acute Coronary Syndrome, Heart Attack, Percutaneous Coronary Intervention (PCI), and Atherectomy. He is licensed to treat patients in New York and Oklahoma. Baber is currently accepting new patients.

His clinical research consists of co-authoring 334 peer reviewed articles and participating in 2 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Usman M. Baber it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Usman M. Baber accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Bright Health
  •  Medica

Call to see if your plan is accepted.
Locations
825 Ne 10th St, Suite 2e, Oklahoma City, OK 73104
Background & Education
Graduate Institution
University Of Texas Southwestern Medical School At Dallas, 2004
Specialties
Interventional Cardiology
Cardiology
Licenses
Internal Medicine in NY
Hospital Affiliations
Oklahoma Childrens Hospital At OU Health
OU Health - University Of Oklahoma Medical Center
Languages Spoken
English
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
XIENCE 28 USA Study
View 1 Less Clinical Trial -

334 Total Publications

Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors